Literature DB >> 16450147

[Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].

H J Lakomek1, W Fiori, K Buscham, J Hülsemann, N Köneke, W Liman, E Märker-Hermann, N Roeder.   

Abstract

Starting with the second year of the so called "convergence period", specialized rheumatological treatment is now represented by a specific DRG (197Z) in the German G-DRG system. The definition of this DRG is based on the procedure codes for the complex and multimodal treatment of rheumatological inpatients (OPS 8-983 and 8-986). This will result in a more appropriate reimbursement of rheumatological treatment. The implementation of specialized rheumatological treatment can be regarded as exemplary for the incorporation of medical specializations into DRG systems. The first step is the definition of the characteristics by procedure codes, which can consequently be utilized within the grouping algorithm. After an inadequate representation of a medical specialization within the DRG system has been demonstrated, a new DRG will be established. As no cost data were available, the calculation of a cost weight for the new G-DRG 197Z is not yet possible for 2006. Hence, reimbursement has to be negotiated between the individual hospital and the budget commission of the health insurers. In this context, the use of clinical pathways is considered helpful.

Mesh:

Year:  2006        PMID: 16450147     DOI: 10.1007/s00393-006-0034-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  5 in total

1.  [Rheumatologic treatment in the G-DRG system].

Authors:  N Roeder; W Fiori; J L Hülsemann; N Könecke; H Lehmann; W Liman; H-J Lakomek
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

2.  [The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].

Authors:  H-J Lakomek; W Fiori; K Buscham; J L Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

3.  Maintenance of exercise in women with fibromyalgia.

Authors:  Patricia L Dobkin; Michal Abrahamowicz; Mary-Ann Fitzcharles; Maria Dritsa; Deborah da Costa
Journal:  Arthritis Rheum       Date:  2005-10-15

4.  [Structural quality of acute internal medicine rheumatology clinics--Project Group of the Association of Rheumatologic Acute Clinics].

Authors:  H J Lakomek; G Neeck; B Lang; J Jung
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

5.  [Clinical pathways: effective and efficient inpatient treatment].

Authors:  N Roeder; P Hensen; D Hindle; N Loskamp; H-J Lakomek
Journal:  Chirurg       Date:  2003-12       Impact factor: 0.955

  5 in total
  11 in total

1.  [What changes for rheumatologists in the G-DRG system 2006?].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; J L Hülsemann; N Köneke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

Review 2.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

3.  [Changes for the field of rheumatology in the G-DRG-System 2007].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; A Wenke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

4.  [The G-DRG system 2008. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; J L Hülsemann; N Roeder
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

5.  [Amendment of the structural quality for inpatient rheumatology. A forward-looking concept].

Authors:  H-J Lakomek; J Braun; E Gromnica-Ihle; C Fiehn; S Claus; C Specker; J Jung; A Krause; H-M Lorenz; J Robbers
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

Review 6.  [The elder patient with a rheumatic disease and comorbidities. Aspects of rheumatology in an ageing population].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

7.  [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].

Authors:  A Zink; J Braun; E Gromnica-Ihle; D Krause; H J Lakomek; W Mau; U Müller-Ladner; J Rautenstrauch; C Specker; M Schneider
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

8.  [§ 116b SGB V (social insurance code, book five) for rheumatology patients. An empirical assessment on the basis of administrative data].

Authors:  T Rath; E Bokern; E Sefo-Bukow; G Büscher; M Lüngen; A Rubbert-Roth
Journal:  Z Rheumatol       Date:  2011-01       Impact factor: 1.372

Review 9.  [Treat-to-target (T2T) from the perspective of inpatient rheumatology].

Authors:  H-J Lakomek; A Krause
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

10.  [How to finance and increase the appeal of rheumatology training : view of the Association of Rheumatology Clinics in Germany (VRA) on challenges and successful strategies].

Authors:  H-J Lakomek; J Robbers; R Koshedub; A Krause; J Braun
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.